DEF 14AThe Ballot
Damora Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2023 · 3y ago · Accession 0000950170-23-015475
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- DEF 14A
- Filing date
- Apr 28, 2023
- Report date
- Jun 14, 2023
- Document
- glto-2023-def_14a.htm
- Size
- 1.2 MB